Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$286,612,197
-$2,952,464 QoQ
Shares Held
1,828,817
-3.5% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#20
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Mar 31, 2022CallValue
$0
CallShares
0
PutValue
$26,325
PutShares
300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $19,103,501,096 across 19 Drug Manufacturers - General names. NVS ranks #10 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,646,119 | $5,572,694,974 | |
| 2 | JNJ |
Johnson & Johnson
|
17,374,433 | $4,412,584,747 | |
| 3 | AMGN |
Amgen Inc
|
7,235,462 | $2,620,105,497 | |
| 4 | ABBV |
AbbVie Inc.
|
9,017,580 | $2,269,183,828 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,658,434 | $1,498,108,767 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,439,586 | $813,577,293 | |
| 7 | PFE |
Pfizer Inc
|
20,193,675 | $486,263,691 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,321,643 | $364,253,067 |
All Filings in NVS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,612,197 | 1,828,817 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $289,564,661 | 1,895,677 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $253,962,466 | 1,842,043 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $234,659,192 | 1,829,844 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $225,474,058 | 1,863,268 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $211,361,729 | 1,895,961 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $184,652,631 | 1,897,571 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $228,182,080 | 1,983,847 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $222,349,586 | 2,088,574 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $194,439,486 | 2,010,126 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $202,298,239 | 2,003,548 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $204,654,971 | 2,009,179 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $208,182,374 | 2,063,050 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $198,785,412 | 2,160,711 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $194,858,938 | 2,147,916 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $176,129,229 | 2,317,185 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $222,188,793 | 2,628,520 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $270,686,285 | 3,084,744 | Shares | Defined | 2022-05-16 | |
| 2022-03-31 | $26,325 | 300 | Put | Defined | 2022-05-16 | |
| 2021-12-31 | $276,933,867 | 3,166,044 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $434,687,604 | 5,315,329 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $492,315,801 | 5,395,833 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $496,852,413 | 5,812,499 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $599,895,185 | 6,352,803 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $571,570,860 | 6,572,802 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $574,228,882 | 6,574,638 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $547,573,617 | 6,641,281 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||